Article Details
Retrieved on: 2023-01-07 19:10:49
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The pharma set the average cost of it and Biogen's newly approved medicine Leqembi to $26,500 per year. Published Jan. 6, 2023.
Article found on: www.biopharmadive.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here